In LMIC countries, poor access to life-saving technologies such as insulin and tools for monitoring blood glucose concentration, high costs of medications, insufficient health care systems, low patient education resulting in insufficient diabetes diagnosis and treatment, and many avoidable deaths and acute emergencies in patients (40). This evidence concerns the gene INS and diabetes mellitus.